logo
I died six times when doctors tried to remove my 40lbs tumor... now 'I see the world differently'

I died six times when doctors tried to remove my 40lbs tumor... now 'I see the world differently'

Daily Mail​10-07-2025
Ariana Pulido had been suffering from a 40lbs tumor so large it pushed her heart into her armpit, and she flatlined each of the time six times doctors tried to remove it - until they were finally successful and Pulido had a new lease on life.
Pulido was only 22 years old when doctors first removed two tumors from her ovaries in July 2023.
She thought her complications were solved, but a month later she was rushed back to the hospital when a sharp pain erupted in her shoulder. Scans detected a third fast-growing tumor on her liver.
Doctors diagnosed her with teratomas, a complication where sex cells like eggs develop into tumors in different parts of the body if they get displaced during development.
Physicians tried to treat Pulido's tumor with chemotherapy, but the mass only grew, ballooning to 10.6-inches in diameter and 40lbs in weight, crushing her lungs, heart and leaving her in a wheelchair and needing oxygen as she struggled to breathe.
She was then diagnosed with growing teratoma syndrome, a condition where chemotherapy leads a teratoma tumor to start expanding in size.
Deeming surgery the only way to reduce the tumor, physicians tried six times, but Pulido's heart flatlined every time they put her to sleep. The team said there was nothing they could do and put her on end-of-life care.
It was then that Pulido was transferred to another hospital, where doctors said they would try to remove the tumor in a new operation — where a machine would perform the function of her heart and lungs.
Teratomas are uncommon, with about 14 out of every 100,000 people diagnosed with the condition every year.
Only about 60 cases of teratomas growing after chemotherapy for ovarian tumors - as is Pulido's case - have been reported previously.
She said in an interview following her treatment: 'The third tumor was... pretty much taking over my whole left side.
'It had moved, my heart was under my armpit, it squished down my lungs.'
The tumor had compressed her heart, which meant that when she was put under anesthesia — which can slow blood flow to the heart and decrease blood pressure — her heart would stop.
In order to prevent Pulido's heart from stopping, doctors at Cedars-Sinai in Los Angeles hooked her up to an ECMO machine, a device that circulates blood for the heart and oxygenates it like the lungs would.
In a marathon 14-hour surgery in May 2024, which involved more than a dozen surgeons, they gradually removed the tumor.
Dr Cristina Ferrone, an oncologist at the hospital who led the treatment, said: 'The tumor was so large and heavy, and it involved such essential blood vessels, that if you injure them, it would be very, very difficult to repair them.
'And an injury like that could quickly lead to death on the operating room table.'
Pulido added: 'The only one that could decide if I do go or stay on that surgery table would be God. And I just had really high hopes and faith that I was going to make it through.'
A motivating force for Pulido to undergo the risky surgery was a future wedding.
Her boyfriend had proposed to her in February 2024 and she was excited for the celebration and to start their dream life together.
The surgery for Pulido was a major success and she was up and walking again just a month later.
Dr Ferrone said: 'When she returned to the clinic a month later, the entire staff and I were amazed.
'Just six weeks earlier, she had been wheeled in, in a wheelchair. Now she walked through the doors.
'She's an incredibly strong young woman and has a wonderfully supportive family.'
Pulido was married on June 21, 2025, a year after the life-changing surgery, in front of her close family and friends.
She is now excited for the next stage of life.
'I feel really good. I feel like a new person,' she said. 'I see the world differently. Every day is a positive day.'
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

WeightWatchers boss says ‘exciting work to do' amid impact of weight loss jabs
WeightWatchers boss says ‘exciting work to do' amid impact of weight loss jabs

The Independent

time2 minutes ago

  • The Independent

WeightWatchers boss says ‘exciting work to do' amid impact of weight loss jabs

WeightWatchers was slower to adapt to the emergence of anti-obesity jabs than rivals, its boss has admitted, as the 62-year-old brand strives to catch up with rapidly evolving attitudes towards weight loss. Tara Comonte, chief executive of the US-based business, said it had a lot of work to do after going through a 'reset'. WeightWatchers recently announced it had emerged from bankruptcy after writing off a portion of the 1.15 billion US dollar (£860 million) debt on its balance sheet. It came as the business was competing with the emergence of GLP-1s – the scientific term for weight loss jabs, which work by reducing food cravings – and a new wave of apps and advice spreading on social media. Ms Comonte told the PA news agency that it 'wasn't as quick to medical weight loss solutions' as some other firms in the US, notably so-called 'telehealth' businesses that offer healthcare remotely. WeightWatchers, which runs some 20,000 workshops each month globally, is now 'at the beginning of the journey' towards forging a new place in the industry and meeting demand from current and future members, Ms Comonte said. 'This whole industry is going through somewhat of a reset and we have exciting work to do,' she told the PA news agency. 'This is a moment where, possibly more than ever before, people are talking about weight, and weight health… where people are seeking more education than ever before, and there are more voices than ever before.' Ms Comonte said the brand was known for 'trust and science' and it was important to harness that 'as there are more and more voices in the ecosystem'. WeightWatchers recently partnered with anti-obesity drugs provider CheqUp in the UK so patients taking the medication can access its 'companion' diet and lifestyle support app. It forms part of its efforts to muscle into the market by offering behavioural strategies and community-based support to people using or coming off the medication. 'There's no 'us and them' anymore,' Ms Comonte told PA, hitting back at weight loss jabs often being pitted as rivals to its model. Dr Kim Boyde, WeightWatchers' newly appointed chief medical officer, said not all its members will want or need weight loss medication – but stressed that it was 'imperative' the programme offers it to those that might benefit. Recent estimates suggest that about 1.5 million people in the UK are taking weight loss jabs. Health officials have suggested that they can help to turn the tide on obesity, but have stressed they are not a silver bullet and do come with side effects.

Roche to investigate whether new drug can delay or prevent Alzheimer's disease
Roche to investigate whether new drug can delay or prevent Alzheimer's disease

Reuters

timean hour ago

  • Reuters

Roche to investigate whether new drug can delay or prevent Alzheimer's disease

July 27 (Reuters) - Swiss drugmaker Roche Holding (ROG.S), opens new tab plans to investigate whether an experimental medicine can delay or prevent Alzheimer's disease symptoms, it said on Sunday, as a part of the company's growing development programme for the disease. The clinical trial of the drug, Trontinemab, will target people who are at risk of cognitive decline and will aim to delay or prevent the symptoms of Alzheimer's, Roche said in a statement. Trontinemab is designed so that the drug is transported across the blood brain barrier—protective blood vessels that prevent chemicals in the bloodstream from entering the brain — in hopes of delivering more of the treatment to the brain. Rivals like Eli Lilly (LLY.N), opens new tab have been making progress in the complicated field of Alzheimer's recently, with Lilly's drug Kisunla getting a recommendation for approval for certain patients from the European Medicines Agency last week. Kisunla is already approved in the U.S. Treatments for Alzheimer's approved so far, including Eisai (4523.T), opens new tab and Biogen's (BIIB.O), opens new tab Leqembi and Lilly's Kisunla, are designed to clear sticky clumps of a protein called amyloid beta in the brain. They carry hefty price tags as well as the risk of serious brain swelling and bleeding.

Roche to test if new drug can prevent Alzheimer's disease, Bloomberg News reports
Roche to test if new drug can prevent Alzheimer's disease, Bloomberg News reports

Reuters

time3 hours ago

  • Reuters

Roche to test if new drug can prevent Alzheimer's disease, Bloomberg News reports

July 27 (Reuters) - Swiss drugmaker Roche Holding (ROG.S), opens new tab plans to test whether an experimental medicine can prevent Alzheimer's disease symptoms in high-risk people, Bloomberg News reported on Sunday. The new late-stage study will target people who are at risk of cognitive decline and aim to slow down the emergence of symptoms or prevent them fully, the report said, citing a statement. The new pre-clinical study is the third largest late-stage trial that the company has announced for its drug trontinemab, which uses an experimental technology called brain shuttle to ferry medicine past the protective blood-brain barrier, according to the report. Rivals like Eli Lilly (LLY.N), opens new tab have been making progress in the complicated field of Alzheimer's recently with Lilly's Alzheimer's drug Kisunla getting recommendation from the European Medicines Agency (EMA) last week. Reuters could not immediately verify the report. Roche did not immediately respond to a request for a comment. Treatments for Alzheimer's approved so far, including Eisai (4523.T), opens new tab and Biogen's (BIIB.O), opens new tab Leqembi, and Eli Lilly's Kisunla, are designed to clear sticky clumps of a protein called amyloid beta in the brain. They also carry hefty price tags and the risk of serious brain swelling and bleeding.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store